Page Contents
There is no routine screening test for acute myeloid leukemia (AML). Most people are diagnosed after seeing a health care provider because of symptoms or abnormal blood test results.
At Fred Hutch Cancer Center, our specialists use advanced laboratory testing to diagnose AML. These tests are used to identify the subtype and genetic changes involved and develop a personalized treatment plan for you.
Acute Myeloid Leukemia Care Tailored to You
You and your family are our top priority. At Fred Hutch Cancer Center, we offer comprehensive and compassionate care — personalized to you. You'll have access to the latest treatment options, clinical trials and supportive care services.
Confirming Your AML Diagnosis
To confirm your AML diagnosis, an experienced Fred Hutch hematopathologist looks carefully at your pathology slides. They look at the type of cells and how the cells behave (morphology). They may use methods such as flow cytometry, molecular testing, cytogenetic testing and next-generation sequencing (testing the cancer cells for gene changes that we can target with treatment).
Our hematopathologists may run more tests on your tissue sample to confirm your diagnosis or get more details about your disease. At your first appointment with us, your physician will go over your diagnosis and test results with you.
Fred Hutch Expertise in AML Diagnosis
To provide the right treatment for you, we will begin by checking details about your disease. We have hematopathologists who specialize in looking at samples of your blood and bone marrow with a microscope. They can tell which subtype you have by carefully studying these tissues and are very experienced in identifying AML subtypes.
Understanding your subtype helps your physician predict how your disease might evolve and which treatments are most likely to work for you. For example, some subtypes respond to certain medicines but not others.